Date: 2014-06-16
Type of information: Fundraising
Company: Oxford BioMedica (UK)
Investors:
Amount: £21.6 million
Funding type: fundraising
Planned used:
Others: * On 29 May 2014, the Board of Oxford BioMedica announced details of a proposed share issue to raise gross proceeds of up to £25.7 million (£23.7 million net of expenses) including a £20 million firm fundraising of 1,000,018,815 new ordinary shares at a price of 2 pence per share and an open offer of up to 283,229,801 New Ordinary Shares at a price of 2 pence per New Ordinary Share. The Company has received valid acceptances in respect of 78,417,099 Open Offer Shares from Qualifying Shareholders. This represents approximately 27.7 per cent. of the Open Offer Shares offered. All eligible applications received from Qualifying Shareholders will be allocated their pre-emption entitlements and all eligible applications under the Excess Application Facility will be allocated their Open Offer Shares as applied for. Consequently, the Company has conditionally raised £21.6 million (before expenses) from the Firm Fundraising and the Open Offer
The Firm Placing and Open Offer remain conditional, amongst other things, upon the passing of the Resolutions at the General Meeting, to be held, 16 June 2014, at 10:00 a.m. and Admission occurring no later than 8.00 a.m. on 17 June 2014 or such later time or date as the parties to the Placing Agreement may determine.
Therapeutic area: Ophtalmalogical diseases - Genetic diseases - Rare diseases
